Relative Value

There is not enough data to reliably calculate the relative value of NK8.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NK8 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

NK8 Competitors Multiples
NuVasive Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
NuVasive Inc
F:NK8
1.9B EUR 1.8 79.6 15.6 42.1
US
Abbott Laboratories
NYSE:ABT
212.2B USD 4.8 15.1 19.3 26.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.9B USD 19.6 68.7 52.5 64
US
Stryker Corp
NYSE:SYK
137.5B USD 5.7 47.1 23 27.8
US
Boston Scientific Corp
NYSE:BSX
136B USD 7 48.6 28.5 38.8
IE
Medtronic PLC
NYSE:MDT
128.4B USD 3.7 26.9 15.1 21.8
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR 2.1 22.7 12.9 18.1
US
Becton Dickinson and Co
NYSE:BDX
58B USD 2.7 35 12.8 21.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD 13.3 54 38.8 43
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 8.4 36.3 25.9 28.4
US
Resmed Inc
NYSE:RMD
37.1B USD 7.1 26 18.6 20.6